NZ222766A - Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing - Google Patents

Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing

Info

Publication number
NZ222766A
NZ222766A NZ222766A NZ22276687A NZ222766A NZ 222766 A NZ222766 A NZ 222766A NZ 222766 A NZ222766 A NZ 222766A NZ 22276687 A NZ22276687 A NZ 22276687A NZ 222766 A NZ222766 A NZ 222766A
Authority
NZ
New Zealand
Prior art keywords
env
vaccines
production
methods
genetic engineering
Prior art date
Application number
NZ222766A
Inventor
Reiner Gentz
Grice Stuart Le
Jan Mous
Dietrich Stuber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ222766A publication Critical patent/NZ222766A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ222766A 1986-12-05 1987-12-01 Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing NZ222766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629116A GB8629116D0 (en) 1986-12-05 1986-12-05 Env/gag polypeptides

Publications (1)

Publication Number Publication Date
NZ222766A true NZ222766A (en) 1990-09-26

Family

ID=10608515

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222766A NZ222766A (en) 1986-12-05 1987-12-01 Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing

Country Status (5)

Country Link
EP (1) EP0270114A3 (en)
JP (1) JPS63156729A (en)
AU (1) AU604793B2 (en)
GB (1) GB8629116D0 (en)
NZ (1) NZ222766A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
JPH0748276A (en) * 1992-03-26 1995-02-21 Inmeru:Kk Preventing vaccine for hiv infectious disease and production thereof
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
NO311807B1 (en) 1999-03-04 2002-01-28 Bionor Immuno As HIV peptides, antigens, vaccine preparations, immunoassay test kits and a method for detecting antibodies induced by HIV
KR20150029678A (en) 2012-06-06 2015-03-18 바이오노르 이뮤노 에이에스 Vaccine
US20170165321A1 (en) 2014-07-11 2017-06-15 Bionor Immuno As Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152928A (en) * 1982-03-06 1983-09-10 Hiroshi Teramachi Four-way loaded linear bearing

Also Published As

Publication number Publication date
AU8190987A (en) 1988-06-16
JPS63156729A (en) 1988-06-29
EP0270114A3 (en) 1990-01-17
AU604793B2 (en) 1991-01-03
GB8629116D0 (en) 1987-01-14
EP0270114A2 (en) 1988-06-08

Similar Documents

Publication Publication Date Title
PL268266A1 (en) The method of manufacture of proteins env virus aids
DE3760912D1 (en) Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
NZ215867A (en) Aids envelope protein, dna vectors and method of production
ES2016426A6 (en) Expression and purification of an HTLV-III gag/env gene protein
NO893149L (en) PROCEDURE FOR MICROBIOLOGICAL PREPARATION OF HUMANT SERUM ALBUMIN AND OTHER HETEROLOGICAL PROTEINS FROM YOURS.
NZ224581A (en) Hiv-2 peptide, aids vaccine
ZA853026B (en) Leukemia-associated virus immunogen,vaccine and assay
DE59006080D1 (en) VACCINE FOR PROTECTION AGAINST HIV VIRUS INFECTIONS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A DIAGNOSTIC AND IMMUNOTHERAPEUTIC.
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
NL189207B (en) FLAVIVIRUS ANTIGEN, PROCESS FOR THE PREPARATION THEREOF, INTERMEDIATES AND PROCESS FOR PREPARING A VACCINE AGAINST JAPANESE ENCEPHALITIS.
NZ222766A (en) Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing
ES8706824A1 (en) EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
DK476688A (en) HIV PROTEINS AND PEPTIDES USED FOR AIDS DIAGNOSIS, PROPHYLAXY AND THERAPY
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
EP0317804A3 (en) Hiv peptides and methods for detection of hiv
NZ226904A (en) Hiv-2 env protein polypeptides and their preparation and use
LTIP1795A (en) Process for preparing protein derived from the envelope gene of human immunodeficiency virus type i and a vaccine containing said protein
EP0267622A3 (en) Method for detecting anti-adult t cell leukemia virus antibody
OA08782A (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
FI95871B (en) A method for producing an HIV particulate immunogen and an antibody thereto
EP0311228A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
ES2011679A6 (en) Sequential polypeptides endowed with immunological activity
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
EP0250128A3 (en) Novel virus isolated from patients with aids
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies